Correlation Between EXXON and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EXXON and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EXXON and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EXXON MOBIL P and Spyre Therapeutics, you can compare the effects of market volatilities on EXXON and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EXXON with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of EXXON and Spyre Therapeutics.

Diversification Opportunities for EXXON and Spyre Therapeutics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between EXXON and Spyre is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding EXXON MOBIL P and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and EXXON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EXXON MOBIL P are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of EXXON i.e., EXXON and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between EXXON and Spyre Therapeutics

Assuming the 90 days trading horizon EXXON MOBIL P is expected to generate 5.15 times more return on investment than Spyre Therapeutics. However, EXXON is 5.15 times more volatile than Spyre Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.07 per unit of risk. If you would invest  8,006  in EXXON MOBIL P on September 4, 2024 and sell it today you would lose (213.00) from holding EXXON MOBIL P or give up 2.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.17%
ValuesDaily Returns

EXXON MOBIL P  vs.  Spyre Therapeutics

 Performance 
       Timeline  
EXXON MOBIL P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EXXON MOBIL P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, EXXON is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

EXXON and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EXXON and Spyre Therapeutics

The main advantage of trading using opposite EXXON and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EXXON position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind EXXON MOBIL P and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing